Drug price history · CMS NADAC read 11 November 2026

What have pharmacies paid for Asenapine since 2013?

What pharmacies pay, not what you pay. Asenapine has 3 products in the CMS NADAC survey, 3 products with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged. Asenapine 10 MG Tablet Sl: $3.68 per unit at the 2021 survey and $2.36 at 2026 (−36%).
Not medical or financial advice. This page reports what pharmacies pay to acquire a drug, from the CMS NADAC survey. It is not what you will be charged, and it says nothing about which medicine is right for you. Ask your pharmacist or prescriber.
Asenapine3 products in NADAC
3products with a price history
  1. Asenapine has 3 products in the CMS NADAC survey, 3 products with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged.
  2. Between each product's first and latest year-end survey, 3 products cost pharmacies less and none costs more, by more than 5 percent, per unit as CMS states it.
  3. This is a per-unit acquisition cost, not a retail price, a copay or an insurer's price, and it says nothing about why a price moved.

Asenapine 10 MG Tablet Sl

Generic

$3.68 per unit at the 2021 year-end survey (6 NDCs) and $2.36 at the 2026 survey (5 NDCs): −36%.

$0$3.682021: median $3.68 per unit, 6 NDCs priced2022: median $2.87 per unit, 6 NDCs priced2023: median $3.28 per unit, 6 NDCs priced2024: median $2.28 per unit, 7 NDCs priced2025: median $2.51 per unit, 5 NDCs priced2026: median $2.36 per unit, 5 NDCs priced202120222023202420252026
year-end median across the NDCs pricedlowest to highest NDC
Year-end surveyMedian per unitLowest to highestNDCs priced
2021 (2021-12-29)$3.686
2022 (2022-12-28)$2.876
2023 (2023-12-27)$3.286
2024 (2024-12-25)$2.287
2025 (2025-12-31)$2.515
2026 (2026-11-11)$2.365

Asenapine 2.5 MG Tablet Sl

Generic

$7.50 per unit at the 2021 year-end survey (3 NDCs) and $3.10 at the 2026 survey (3 NDCs): −59%.

$0$7.502021: median $7.50 per unit, 3 NDCs priced2022: median $3.46 per unit, 4 NDCs priced2023: median $3.39 per unit, 4 NDCs priced2024: median $2.72 per unit, 5 NDCs priced2025: median $3.15 per unit, 3 NDCs priced2026: median $3.10 per unit, 3 NDCs priced202120222023202420252026
year-end median across the NDCs pricedlowest to highest NDC
Year-end surveyMedian per unitLowest to highestNDCs priced
2021 (2021-12-29)$7.503
2022 (2022-12-28)$3.464
2023 (2023-12-27)$3.394
2024 (2024-12-25)$2.725
2025 (2025-12-31)$3.153
2026 (2026-11-11)$3.103

Asenapine 5 MG Tablet Sl

Generic

$3.92 per unit at the 2021 year-end survey (6 NDCs) and $2.09 at the 2026 survey (5 NDCs): −47%.

$0$3.922021: median $3.92 per unit, 6 NDCs priced2022: median $3.63 per unit, 6 NDCs priced2023: median $2.92 per unit, 6 NDCs priced2024: median $2.07 per unit, 7 NDCs priced2025: median $2.27 per unit, 5 NDCs priced2026: median $2.09 per unit, 5 NDCs priced202120222023202420252026
year-end median across the NDCs pricedlowest to highest NDC
Year-end surveyMedian per unitLowest to highestNDCs priced
2021 (2021-12-29)$3.926
2022 (2022-12-28)$3.636
2023 (2023-12-27)$2.926
2024 (2024-12-25)$2.077
2025 (2025-12-31)$2.275
2026 (2026-11-11)$2.095

CMS National Average Drug Acquisition Cost, year-end surveys 2013 to 2026. A pharmacy acquisition cost, not a retail price. About NADAC.

Where does Asenapine sit on the generic price cliff?

Asenapine 10 MG Tablet Sl: the first generic approval in its Orange Book group is dated 2020. Its year-end acquisition cost in 2026 is 64% of its first observed year-end price (2021). The median matched product, 6 years after its first generic approval, is at 45% (the middle half runs from 16% to 87%), so this product is inside that middle half.

0%25%50%75%100%0 years after the first generic approval: median 100%, middle half 100% to 100%, 79 products1 years after the first generic approval: median 95%, middle half 71% to 100%, 118 products2 years after the first generic approval: median 80%, middle half 49% to 99%, 135 products3 years after the first generic approval: median 64%, middle half 36% to 90%, 142 products4 years after the first generic approval: median 55%, middle half 25% to 84%, 154 products5 years after the first generic approval: median 46%, middle half 16% to 80%, 154 products6 years after the first generic approval: median 45%, middle half 16% to 87%, 154 products7 years after the first generic approval: median 40%, middle half 14% to 71%, 153 products8 years after the first generic approval: median 32%, middle half 8% to 65%, 131 products9 years after the first generic approval: median 28%, middle half 7% to 67%, 109 products10 years after the first generic approval: median 22%, middle half 5% to 53%, 90 products11 years after the first generic approval: median 21%, middle half 5% to 51%, 79 products12 years after the first generic approval: median 16%, middle half 6% to 34%, 48 products13 years after the first generic approval: median 19%, middle half 14% to 39%, 23 productsAsenapine 10 MG Tablet Sl, 1 years after the first generic approval: 100% of its first observed price, 6 NDCs pricedAsenapine 10 MG Tablet Sl, 2 years after the first generic approval: 78% of its first observed price, 6 NDCs pricedAsenapine 10 MG Tablet Sl, 3 years after the first generic approval: 89% of its first observed price, 6 NDCs pricedAsenapine 10 MG Tablet Sl, 4 years after the first generic approval: 62% of its first observed price, 7 NDCs pricedAsenapine 10 MG Tablet Sl, 5 years after the first generic approval: 68% of its first observed price, 5 NDCs pricedAsenapine 10 MG Tablet Sl, 6 years after the first generic approval: 64% of its first observed price, 5 NDCs priced024681012years since the first generic approval
median of 200 matched productsmiddle halfeach productAsenapine 10 MG Tablet Sl

This is a pattern in matched products. It does not say the first generic caused the fall, and it does not say this product's price will follow the median. See it with other drugs.

Where can you go from this record?

Open it in the check to search another drug, or see the CMS pharmacy pricing page for what NADAC measures. To check whether a drug is in shortage, see the FDA drug shortages page.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the CMS pharmacy pricing page, year-end surveys 2013 to 2026 (latest 11 November 2026).